• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

107 例慢性恰加斯病成人患者的临床特征和结局及寄生虫学治愈标准。

Clinical characteristics and outcome of 107 adult patients with chronic Chagas disease and parasitological cure criteria.

机构信息

Departamento de Cardiología, Hospital Eva Perón, San Martín, Buenos Aires, Argentina.

出版信息

Trans R Soc Trop Med Hyg. 2013 Jun;107(6):372-6. doi: 10.1093/trstmh/trt029. Epub 2013 Apr 23.

DOI:10.1093/trstmh/trt029
PMID:23612468
Abstract

BACKGROUND

The cure in adult patients with chronic Chagas disease and the relationship between parasitological and clinical evolution is still under debate. The aim of this study was to analyze the clinical, epidemiological and progression features of the disease in a patient population who became serologically negative either spontaneously or post-etiological treatment.

METHODS

We included 107 patients over 20 years old with three different confirmed reactive anti-Trypanosoma cruzi serologic tests on admission, and a minimum of two years of follow-up. Patients were assigned to clinical groups according to Kuschnir. Change of clinical group was considered a heart disease progression criterion, and seronegative conversion of two or three as parasitological cure criterion.

RESULTS

From 107 patients with parasitological cure, 82 had received treatment (77%) and 25 became spontaneously seronegative (23%). Forty-six (43%) and 61 (57%) patients had two and three negative serological tests, respectively. No differences in clinical groups, ECG, echocardiogram and heart disease progression were found in patients who became negative spontaneously or post-treatment. The clinical progression and ECG changes were observed in 5/107 (5%) and 11/107 (10%) respectively, in a mean of 10 years follow-up.

CONCLUSIONS

Adults with chronic Chagas disease can cure, mostly post-etiological treatment, but also spontaneously, showing a favourable clinical outcome.

摘要

背景

成人慢性恰加斯病的治愈以及寄生虫学和临床演变之间的关系仍存在争议。本研究旨在分析经血清学检测证实为反应性抗克氏锥虫抗体的 107 例患者的临床、流行病学和疾病进展特征,这些患者在入院时至少进行了三次血清学检查,且随访时间至少为两年。根据 Kuschnir 标准,我们将患者分为不同的临床组。临床组别的变化被视为心脏病进展的标准,两次或三次血清学阴性转换被视为寄生虫学治愈的标准。

方法

我们纳入了 107 例年龄超过 20 岁的患者,他们在入院时至少进行了三次血清学检查,且结果均为反应性抗克氏锥虫抗体,随访时间至少为两年。根据 Kuschnir 标准,我们将患者分为不同的临床组。临床组别的变化被视为心脏病进展的标准,两次或三次血清学阴性转换被视为寄生虫学治愈的标准。

结果

在 107 例寄生虫学治愈的患者中,82 例接受了治疗(77%),25 例为自发性血清学阴性(23%)。46 例(43%)和 61 例(57%)患者分别进行了两次和三次阴性血清学检测。在自发性和治疗后血清学阴性的患者中,临床组、心电图、超声心动图和心脏病进展没有差异。在平均 10 年的随访中,分别有 5/107(5%)和 11/107(10%)的患者出现临床进展和心电图改变。

结论

成人慢性恰加斯病可以治愈,大多数是在病因治疗后,但也有自发性治愈,且预后良好。

相似文献

1
Clinical characteristics and outcome of 107 adult patients with chronic Chagas disease and parasitological cure criteria.107 例慢性恰加斯病成人患者的临床特征和结局及寄生虫学治愈标准。
Trans R Soc Trop Med Hyg. 2013 Jun;107(6):372-6. doi: 10.1093/trstmh/trt029. Epub 2013 Apr 23.
2
Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.在使用苯硝唑治疗的小鼠中,PCR阳性组织的持续存在,这些小鼠在感染来自不同基因型的克氏锥虫株的双重感染中,血液寄生虫学和血清学检测呈阴性。
J Antimicrob Chemother. 2008 Jun;61(6):1319-27. doi: 10.1093/jac/dkn092. Epub 2008 Mar 13.
3
Prediction of parasitological cure in children infected with Trypanosoma cruzi using a novel multiplex serological approach: an observational, retrospective cohort study.采用新型多重血清学方法预测感染克氏锥虫的儿童的寄生虫学治愈情况:一项观察性、回顾性队列研究。
Lancet Infect Dis. 2021 Aug;21(8):1141-1150. doi: 10.1016/S1473-3099(20)30729-5. Epub 2021 Apr 6.
4
Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country.PCR 在监测慢性恰加斯病患者贝那唑嗪反应中的作用:一个非流行国家的前瞻性研究。
J Antimicrob Chemother. 2010 Aug;65(8):1759-64. doi: 10.1093/jac/dkq201. Epub 2010 Jun 11.
5
Evaluation of the ELISA-F29 test as an early marker of therapeutic efficacy in adults with chronic Chagas disease.评估ELISA-F29检测作为慢性恰加斯病成年患者治疗疗效早期标志物的情况。
Rev Inst Med Trop Sao Paulo. 2013;55(3). doi: 10.1590/S0036-46652013000300005.
6
Long term evaluation of etiological treatment of chagas disease with benznidazole.使用苯硝唑对恰加斯病进行病因治疗的长期评估。
Rev Inst Med Trop Sao Paulo. 2002 Jan-Feb;44(1):29-37.
7
Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests.恰加斯病的治疗后治愈标准:常规血清学检查后进行补充血清学、寄生虫学和分子检测。
Clin Vaccine Immunol. 2012 Aug;19(8):1283-91. doi: 10.1128/CVI.00274-12. Epub 2012 Jun 27.
8
Seronegative conversion after incomplete benznidazole treatment in chronic Chagas disease.慢性恰加斯病不完全苯达唑治疗后的血清学阴转。
Trans R Soc Trop Med Hyg. 2012 Oct;106(10):636-8. doi: 10.1016/j.trstmh.2012.07.010. Epub 2012 Aug 13.
9
Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction.通过聚合酶链反应诊断和监测的先天性恰加斯病的病因治疗。
J Antimicrob Chemother. 2003 Sep;52(3):441-9. doi: 10.1093/jac/dkg338. Epub 2003 Aug 13.
10
Serological profiles and evaluation of parasitaemia by PCR and blood culture in individuals chronically infected by Trypanosoma cruzi treated with benzonidazole.慢性感染克氏锥虫的个体经苯硝唑治疗后的血清学特征及寄生虫血症的 PCR 和血培养评估。
Trop Med Int Health. 2012 Mar;17(3):368-73. doi: 10.1111/j.1365-3156.2011.02936.x. Epub 2011 Dec 30.

引用本文的文献

1
Bimodal distributions of anti-Trypanosoma cruzi antibody levels in blood donors are associated with parasite detection and antibody waning in peripheral blood.献血者血液中抗克氏锥虫抗体水平的双峰分布与外周血中寄生虫检测及抗体衰减有关。
PLoS Negl Trop Dis. 2025 May 30;19(5):e0012724. doi: 10.1371/journal.pntd.0012724. eCollection 2025 May.
2
Impact of antiparasitic therapy on cardiovascular outcomes in chronic Chagas disease. A systematic review and meta-analysis.抗寄生虫治疗对慢性恰加斯病心血管结局的影响。一项系统评价和荟萃分析。
EClinicalMedicine. 2024 Dec 24;79:102972. doi: 10.1016/j.eclinm.2024.102972. eCollection 2025 Jan.
3
Five-year serological and clinical evolution of chronic Chagas disease patients in Cochabamba, Bolivia.
玻利维亚科恰班巴慢性恰加斯病患者的 5 年血清学和临床演变。
PLoS Negl Trop Dis. 2023 Dec 29;17(12):e0011498. doi: 10.1371/journal.pntd.0011498. eCollection 2023 Dec.
4
Chronic Chagas Disease-the Potential Role of Reinfections in Cardiomyopathy Pathogenesis.慢性恰加斯病——再感染在心肌病发病机制中的潜在作用。
Curr Heart Fail Rep. 2022 Oct;19(5):279-289. doi: 10.1007/s11897-022-00568-9. Epub 2022 Aug 11.
5
Use of benznidazole to treat chronic Chagas disease: An updated systematic review with a meta-analysis.使用苯唑达唑治疗慢性恰加斯病:一项更新的系统评价与荟萃分析。
PLoS Negl Trop Dis. 2022 May 16;16(5):e0010386. doi: 10.1371/journal.pntd.0010386. eCollection 2022 May.
6
Serological response to nifurtimox in adult patients with chronic Chagas disease: An observational comparative study in Argentina.慢性恰加斯病成人患者对硝呋替莫的血清学反应:阿根廷的一项观察性比较研究。
PLoS Negl Trop Dis. 2021 Oct 4;15(10):e0009801. doi: 10.1371/journal.pntd.0009801. eCollection 2021 Oct.
7
A refined genome phage display methodology delineates the human antibody response in patients with Chagas disease.一种优化的基因组噬菌体展示方法描绘了恰加斯病患者的人类抗体反应。
iScience. 2021 May 15;24(6):102540. doi: 10.1016/j.isci.2021.102540. eCollection 2021 Jun 25.
8
Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study.苯硝唑可降低慢性恰加斯病进展和心血管事件的风险:一项长期随访研究。
EClinicalMedicine. 2020 Dec 23;31:100694. doi: 10.1016/j.eclinm.2020.100694. eCollection 2021 Jan.
9
Trypanocidal drugs for late-stage, symptomatic Chagas disease (Trypanosoma cruzi infection).用于晚期有症状的恰加斯病(克氏锥虫感染)的杀锥虫药物。
Cochrane Database Syst Rev. 2020 Dec 11;12(12):CD004102. doi: 10.1002/14651858.CD004102.pub3.
10
Declining antibody levels to Trypanosoma cruzi correlate with polymerase chain reaction positivity and electrocardiographic changes in a retrospective cohort of untreated Brazilian blood donors.在未经治疗的巴西献血者的回顾性队列中,抗 Trypanosoma cruzi 抗体水平下降与聚合酶链反应阳性和心电图改变相关。
PLoS Negl Trop Dis. 2020 Oct 27;14(10):e0008787. doi: 10.1371/journal.pntd.0008787. eCollection 2020 Oct.